Company / Operating Income per Share
Aligos Therapeutics, Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.10
FY2025
5-year range
-$29.68 / -$1.10
FY2021-FY2025
Trend
+96.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 6 years, ranging from $-29.68 in FY2024 to $-1.10 in FY2025.
Based on SEC 10-K filings.
-1.10 in FY2025.
Improved from $-2.27 to $-1.10 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 96.3% year-over-year.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.10 | +96.3% |
| FY2024 | -$29.68 | -1205.5% |
| FY2023 | -$2.27 | +24.4% |
| FY2022 | -$3.01 | -17.1% |
| FY2021 | -$2.57 | +81.3% |
| FY2020 | -$13.76 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026